Suppressive effects of combination therapy with mizoribine and FK 506 on the development of accelerated coronary artery disease and myocardial rejection after heart transplantation.
Ogawa
N
N
Department of Surgery, Saitama Medical School, Japan.
Koyama
I
I
Shibata
T
T
Watanabe
T
T
Akimoto
N
N
Taguchi
Y
Y
Shinozuka
N
N
Omoto
R
R
D000818:Animals; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000473:pathology / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006937:Hypercholesterolemia; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D011817:Rabbits; D012263:Ribonucleosides / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D002784:Cholesterol; D016559:Tacrolimus